Alnylam Pharmaceuticals
ALNY
#445
Rank
S$67.96 B
Marketcap
S$514.43
Share price
-1.93%
Change (1 day)
56.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company